ImmunoPrecise Antibodies News

ImmunoPrecise Antibodies Analyst Ratings

BenzingaMar 15 09:23 ET

Buy Rating Affirmed: ImmunoPrecise Antibodies' Growth and Innovation Drive Positive Outlook

TipRanksMar 15 06:15 ET

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

BenzingaSep 18, 2023 06:54 ET

ImmunoPrecise Antibodies Analyst Ratings

BenzingaSep 18, 2023 06:53 ET

ImmunoPrecise Antibodies (IPA) Receives a Buy From H.C. Wainwright

TipRanksSep 18, 2023 06:25 ET

Analysts Are Bullish on Top Healthcare Stocks: Acasti Pharma (ACST), ImmunoPrecise Antibodies (IPA)

TipRanksJul 12, 2023 06:20 ET

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

BenzingaJul 12, 2023 06:09 ET

ImmunoPrecise Antibodies Analyst Ratings

BenzingaJul 12, 2023 06:07 ET

Benchmark Reiterates Speculative Buy on ImmunoPrecise Antibodies, Maintains $7 Price Target

BenzingaJul 11, 2023 08:09 ET

Benchmark Maintains Speculative Buy on ImmunoPrecise Antibodies, Lowers Price Target to $7

BenzingaMar 21, 2023 12:32 ET

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

BenzingaMar 17, 2023 11:31 ET

ImmunoPrecise Antibodies (IPA) Gets a Buy From H.C. Wainwright

TipRanksMar 17, 2023 10:27 ET

Analysts Are Bullish on Top Healthcare Stocks: Rigel (RIGL), ImmunoPrecise Antibodies (IPA)

TipRanksDec 22, 2022 11:15 ET

HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9

Benzinga Real-time NewsDec 2, 2022 06:34 ET